Skip to main content

Advertisement

Table 2 Characteristics of the study population

From: Severe tooth wear in Prader-Willi syndrome. A case–control study

  PWS group (n = 49) Control group (n = 49)
Age range (years) 6.5-40.9 6.1-42.5
Mean age ± s.d. 20.4 ± 9.5 20.8 ± 10.1
Number of individuals n n
Age group 6-18 years 23 23
Age group 19-40 years 26 26
Males/females 25/24 25/24
Supplementary diseases   
Diabetes 3 0
Epilepsy 3 0
Heart disease 1 0
Daytime sleepiness or Sleep apnea 20 0
BMI   
Normal weight 14 49
Overweight 17 0
Obese 18 0
Medication   
Growth hormone (GH) a 42 0
  1. BMI criteria were age- and gender adjusted for individuals 6-18 years according to International Obesity Task Force (IONT) (37).
  2. aDuration of GH treatment ranged between 6 and 192 months. Mean duration was 72 months.